Biodefense has quietly moved from a public-health niche to a core national-security challenge — but most people still treat biology as healthcare, not infrastructure.
This week, I sat down with Max Breet, who went from military → Anduril → now leading biosecurity work at Ginkgo Bio. Few people have seen the shift from kinetic defence to biological risk as clearly as he has.
We talk about how cheap tools, AI and geopolitical competition are transforming biology into a strategic domain; the real (non-sci-fi) scenarios governments should prepare for; and what a “biological radar” looks like when deployed both conflict and civil zones.
A conversation for anyone thinking about the future of defence beyond drones, autonomy and EW.
To learn more:
- Hoover Report on Biology (https://www.hoover.org/research/biosecurity-really-strategy-victory)
- Gingko Newsletter on Biodefense (https://thesignalbio.substack.com/p/introducing-the-signal)